Candriam Equities L Oncology Impact I/ LU1864482358 /
| NAV9/19/2024 | Chg.+22.3499 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 3,098.3899USD | +0.73% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 9/21/2024 | Public WebStation Live Factsheet | 2024 | English | - |
| 6/30/2024 | Semi-annual report | 2024 | German | 2,233.87 KB |
| 6/30/2024 | Semi-annual report | 2024 | English | 2,123.71 KB |
| 6/3/2024 | Prospectus | 2024 | English | 3,663.84 KB |
| 6/3/2024 | Prospectus | 2024 | German | 5,520.88 KB |
| 3/1/2024 | PRIIP Key Information Document | 2024 | German | 269.75 KB |
| 3/1/2024 | PRIIP Key Information Document | 2024 | English | 261.56 KB |
| 12/31/2023 | Account statment | 2023 | English | 5,416.37 KB |
| 12/31/2023 | Account statment | 2023 | German | 4,732.66 KB |
| 7/2/2022 | Key Investor Information | 2022 | German | 363.78 KB |
